{
    "name": "follitropin alfa",
    "comment": "Rx",
    "other_names": [
        "Gonal-f",
        "Gonal-f RFF"
    ],
    "classes": [
        "Gonadotropins",
        "Ovulation Stimulators"
    ],
    "source": "https://reference.medscape.com/drug/gonal-f-rff-follitropin-alfa-342804",
    "pregnancy": {
        "common": [
            "Drug not indicated in pregnant women",
            "The incidence of congenital malformations after some assisted reproductive technology, specifically in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI)], maybe slightly higher than that after spontaneous conception; this slightly higher incidence is thought to be related to differences in parental characteristics (eg, maternal age, maternal and paternal genetic background, sperm characteristics) and to a higher incidence of multi-fetal gestations after IVF or ICSI; there is no human data that the use of womens-health-reproduction#gonadotropins (including drug alone or as part of IVF or ICSI cycles, increases risk of congenital malformations",
            "Risk of spontaneous abortion (miscarriage) is increased in women who have used womens-health-reproduction#gonadotropins products (including GONAL-F) to achieve pregnancy",
            "Verify a negative pregnancy test before administering drug"
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "In animal studies, the continuous administration of recombinant human FSH during pregnancy resulted in a decrease in number of viable fetuses and difficult and prolonged delivery; no teratogenic effect observed"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "There are no data on presence of drug in human milk, effects on breastfed infant, or on milk production; because secretion of prolactin during lactation can result in inadequate response to ovarian stimulation, advise women not to breastfeed during treatment"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Prior hypersensitivity to recombinant FSH preparations",
                "High levels of FSH indicating primary gonadal failure",
                "Uncontrolled thyroid or adrenal dysfunction",
                "Sex hormone dependent tumors of the reproductive tract and accessory organs",
                "Organic intracranial lesion (e.g. pituitary tumor)",
                "Women with abnormal uterine bleeding of undetermined origin; ovarian cyst or enlargement of undetermined origin",
                "Pregnancy"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "May cause ovarian hyperstimulation syndrome (OHSS, dramatic increase in vascular permeability which can result in rapid fluid accumulation in peritoneal cavity, thorax and pericardium; accompanied by severe pelvic pain, nausea, vomiting and weight gain) in women with or without pulmonary or vascular complications",
                "If ovaries are abnormally enlarged on last day of therapy, inform women not to administer hCG and to avoid intercourse",
                "Pulmonary conditions (atelactasis, ARDS, & asthma exacerbation) have been reported; in women with recognized risk factors, the benefits of induction of ovulation and ART need to be weighed against risks; during or after use of drug, monitor for venous or arterial thromboembolic events ",
                "Possibility of multiple births (range 12.3%-44.0% live births)",
                "In ovarian torsion, early diagnosis and immediate detorsion limit damage to ovary due to reduced blood supply",
                "A thorough gynecologic & endocrinological evaluation should be conducted prior to treatment to rule out primary ovarian failure, early pregnancy & partner's fertility potential",
                "The rate of multiple births is dependent on number of embryos transferred; advise the woman and her partner of the potential risk of multi-fetal gestation and birth before beginning therapy",
                "Advise women who become pregnant following ART and have: abdominal/pelvic pain (particularly on one side); shoulder, neck or rectal pain; and nausea and vomiting to seek immediate medical attention; confirm the presence of an intrauterine pregnancy early by Î²-hCG testing and transvaginal ultrasound",
                "The risk of spontaneous abortion (miscarriage) is increased with gonadotropin products, however, causality has not been established",
                "Both benign and malignant ovarian neoplasms are reported in women who have had multiple drug therapy for controlled ovarian stimulation, however, causality has not been established"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Intermenstrual bleeding",
            "percent": null
        },
        {
            "name": "Ovarian hyperstimulation",
            "percent": null
        },
        {
            "name": "Abdominal pain",
            "percent": null
        },
        {
            "name": "Acne",
            "percent": null
        },
        {
            "name": "Flatulence",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Back pain",
            "percent": null
        },
        {
            "name": "Emotional lability",
            "percent": null
        },
        {
            "name": "Diarrhea",
            "percent": null
        },
        {
            "name": "Dizziness",
            "percent": null
        },
        {
            "name": "OHSS",
            "percent": null
        },
        {
            "name": "for ovulation induction",
            "percent": null
        },
        {
            "name": "Flatulence",
            "percent": null
        },
        {
            "name": "Acne",
            "percent": null
        },
        {
            "name": "Toothache",
            "percent": null
        },
        {
            "name": "Intermenstrual bleeding",
            "percent": null
        },
        {
            "name": "Breast pain",
            "percent": null
        },
        {
            "name": "Injection site reactions",
            "percent": null
        },
        {
            "name": "Ovarian cyst",
            "percent": null
        },
        {
            "name": "Nausea",
            "percent": null
        },
        {
            "name": "Sinusitis",
            "percent": null
        }
    ]
}